(S)-2-(2-CHLOROPHENYL)-2-((2-(THIOPHEN-2-YL)ETHYL)AMINO)ACETIC ACID, 95%, 1g

4-ETHYLBENZENESULFONIC ACID, 95%, 5g

Prise de laboratoire Type 1, 240 x 240 mm, 1 pièce

2-Methyl-2H-indazol-4-ol, 97.0%, 1g

2,6,8-Trimethylquinolin-4(1H)-one, 98%, 5g

Huile de noix, raffinée, 500 ml, emballage en verre

(2E)-1-(2-chlorophenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxycarbonyl)piperazin-2-yl)acetic acid, 98%, 1g

2-[(6-Ethoxy-pyrimidin-4-ylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

3,4-Dimethoxytoluene, 99.0%, 25g

N-Boc-Propargylglycine methyl ester, 97.0%, 250mg

4-Amino-2,5-dimethylbenzoic acid, 95.0%, 250mg

5-Bromo-1H-indene-1,3(2H)-dione, 98%, 5g